Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar (ZRDT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00549003 |
Recruitment Status :
Completed
First Posted : October 25, 2007
Last Update Posted : October 25, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Malaria | Device: Rapid Diagnostic Test for P. falciparum malaria | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 9346 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar |
Study Start Date : | February 2005 |
Actual Study Completion Date : | August 2005 |
- Device: Rapid Diagnostic Test for P. falciparum malaria
Other Name: Paracheck Pf, Manufactured by Orchid Biomedical Systems, Goa, INDIA.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Any patient attending the study sites and reporting history of fever within past 48 hours or other symptoms compatible with malaria and giving their informed consent, will be eligible for the study.
Exclusion Criteria:
- Patient's refusal to consent will disqualify participation in the study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00549003
Tanzania | |
Muyuni, Uzini, Kinyasini and Mzambarauni Primary Health Care Units | |
Zanzibar, Tanzania |
Study Director: | Anders Björkman, MD,PhD | Karolinska UH | |
Principal Investigator: | Mwinyi I Msellem, HLSO | Karolinska UH |
ClinicalTrials.gov Identifier: | NCT00549003 |
Other Study ID Numbers: |
ZRDT 2005 |
First Posted: | October 25, 2007 Key Record Dates |
Last Update Posted: | October 25, 2007 |
Last Verified: | October 2007 |
Malaria Protozoan Infections Parasitic Diseases Infections Vector Borne Diseases |